LRMR: Harlow John B. Jr. discloses securities transactions
By AlphaYouPublished Form 4
Harlow John B. Jr.
Reporting filer
Harlow John B. Jr. reported Grant or award in Larimar Therapeutics, Inc.: 50000 units of Common Stock, dated 2026-09-29. The full Form 4 contains 2 transaction entries.
- Disclosed
- Oct 1, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Harlow John B. Jr. | 2026-09-29 | A | Grant or award | 50000 | 0.00 | 50,000 | 2 days | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Harlow John B. Jr. | 2026-09-29 | A | Grant or award | 800000 | 0.00 | 800,000 | 2 days | Filed terms
|
Common Stock
- Owner
- Harlow John B. Jr.
- Date
- 2026-09-29
- Code
- A
- Action
- Grant or award
- Quantity
- 50000
- Price
- 0.00
- Following holdings
- 50,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 50000
- id: F1
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 50000
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Harlow John B. Jr.
- Date
- 2026-09-29
- Code
- A
- Action
- Grant or award
- Quantity
- 800000
- Price
- 0.00
- Following holdings
- 800,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 3.14
- transaction Date: 2026-09-29
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 800000
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: A
- id: F2
- expiration Date: 2036-09-29
- underlying Security Title: Common Stock
- underlying Security Shares: 800000
- shares Owned Following Transaction: 800000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Harlow John B. Jr.: President and COO.
- F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- F2: The option vests 25% on September 29, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.